Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Comfort of Iomeprol 300 in CT Contrast-Enhanced Imaging
ChiCTR2300070917Phase 4Not yet recruiting
- Sponsor
- Leshan People's Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iomeprol, sponsored by Leshan People's Hospital. Primary endpoint: Adverse events. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
iomeprol
Beyond the preview
Go deeper on ChiCTR2300070917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070917.